Citius Oncology grants Carol Webb 125,000 stock options
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Citius Oncology director Carol Webb received 125,000 stock options on November 12, 2026, with an exercise price of $0.5223 per share. The options vest in full on November 12, 2027, subject to her Continuous Service to Citius Oncology or a related entity, and expire November 12, 2036; no Rule 10b5-1 plan is reported. The filing also lists 300,000 shares underlying restricted stock units granted September 19, 2025, and two other option positions: 125,000 shares at $1.07 and 150,000 shares at $2.15.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 125,000 | $0.00 | $0.00 |
| Holding | Stock Option (Right to Buy) F3 | -- | -- | -- |
| Holding | Stock Option (Right to Buy) F4 | -- | -- | -- |
| Holding | Common Stock F1 | -- | -- | -- |
Footnotes (4)
- F1. Represents restricted stock units granted on September 19, 2025. The shares underlying the restricted stock units will vest in full on the third anniversary of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
- F2. These options were granted on November 12, 2026. The options vest in full on November 12, 2027, subject to the Reporting Person's Continuous Service to the Company or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
- F3. These options were granted on December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, subject to the Reporting Person's Continuous Service to the Company or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
- F4. These options are 100% vested.
Key Figures
Key Terms
restricted stock units financial
Continuous Service technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many stock options did Citius Oncology (CTOR) director Carol Webb receive?
What other stock options does Carol Webb hold at Citius Oncology (CTOR)?
AI-generated analysis. How Rhea-AI works. Not financial advice.